Venture Life Group manages a growing portfolio of non-prescription healthcare brands focused on ageing consumers, supported by its integrated product development and manufacturing model. The shares trade on a low multiple, particularly given that VLG will report positive EBITDA in 2016, has revenue momentum and prospects of near term, self-sustaining profitability.
26 Jan 2017
A Year of Maiden Profitability
Sign up to access
Get access to our full offering from over 30 providers
Get access to our full offering from over 30 providers
A Year of Maiden Profitability
Venture Life Group Plc (VLG:LON) | 42.2 0.1 0.6% | Mkt Cap: 53.4m
- Published:
26 Jan 2017 -
Author:
Emma Ulker -
Pages:
2
Venture Life Group manages a growing portfolio of non-prescription healthcare brands focused on ageing consumers, supported by its integrated product development and manufacturing model. The shares trade on a low multiple, particularly given that VLG will report positive EBITDA in 2016, has revenue momentum and prospects of near term, self-sustaining profitability.